These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 23617428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glycopeptide antibiotics: from conventional molecules to new derivatives.
    Van Bambeke F, Van Laethem Y, Courvalin P, Tulkens PM.
    Drugs; 2004; 64(9):913-36. PubMed ID: 15101783
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A facile Fmoc solid phase synthesis strategy to access epimerization-prone biosynthetic intermediates of glycopeptide antibiotics.
    Brieke C, Cryle MJ.
    Org Lett; 2014 May 02; 16(9):2454-7. PubMed ID: 24730694
    [Abstract] [Full Text] [Related]

  • 7. [Chemical modification of glycopeptide antibiotics].
    Pavlov AIu, Preobrazhenskaia MN.
    Bioorg Khim; 1998 Sep 02; 24(9):644-62. PubMed ID: 9813730
    [Abstract] [Full Text] [Related]

  • 8. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    Maples KR, Wheeler C, Ip E, Plattner JJ, Chu D, Zhang YK, Preobrazhenskaya MN, Printsevskaya SS, Solovieva SE, Olsufyeva EN, Heine H, Lovchik J, Lyons CR.
    J Med Chem; 2007 Jul 26; 50(15):3681-5. PubMed ID: 17608397
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci.
    Ravizzola G, Pirali F, Foresti I, Turano A.
    Drugs Exp Clin Res; 1987 Jul 26; 13(4):225-9. PubMed ID: 2957187
    [Abstract] [Full Text] [Related]

  • 11. [Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics].
    Olsuf'eva EN, Preobrazhenskaia MN.
    Bioorg Khim; 2006 Jul 26; 32(4):339-59. PubMed ID: 16909859
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glycopeptides in clinical development: pharmacological profile and clinical perspectives.
    Van Bambeke F.
    Curr Opin Pharmacol; 2004 Oct 26; 4(5):471-8. PubMed ID: 15351351
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. First and second generation total synthesis of the teicoplanin aglycon.
    Boger DL, Kim SH, Mori Y, Weng JH, Rogel O, Castle SL, McAtee JJ.
    J Am Chem Soc; 2001 Mar 07; 123(9):1862-71. PubMed ID: 11456806
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Design of Novel Carboxamides of Eremomycin and Vancomycin with 4- or 3-Amino Methyl Phenyl Boric Acid and Their Investigation].
    Bychkova EN, Korolev AM, Olsufyeva EN, Mirchink EP, Isakova EB.
    Antibiot Khimioter; 2015 Mar 07; 60(9-10):7-11. PubMed ID: 27141632
    [Abstract] [Full Text] [Related]

  • 19. Vancomycin resistance: are there better glycopeptides coming?
    Linden PK.
    Expert Rev Anti Infect Ther; 2008 Dec 07; 6(6):917-28. PubMed ID: 19053904
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.